Provided by Tiger Trade Technology Pte. Ltd.

United Therapeutics

545.00
+3.380.62%
Post-market: 545.000.00000.00%19:45 EDT
Volume:1.01M
Turnover:550.71M
Market Cap:23.38B
PE:19.50
High:558.30
Open:542.41
Low:541.90
Close:541.62
52wk High:609.35
52wk Low:409.07
Shares:42.89M
Float Shares:39.35M
Volume Ratio:0.61
T/O Rate:2.55%
Dividend:- -
Dividend Rate:- -
EPS(TTM):27.95
EPS(LYR):27.86
ROE:19.31%
ROA:11.61%
PB:3.65
PE(LYR):19.56

Loading ...

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Jul 10

BofA Securities Adjusts United Therapeutics Price Target to $613 From $620

MT Newswires Live
·
Jul 10

United Therapeutics price target lowered to $613 from $620 at BofA

TIPRANKS
·
Jul 10

United Therapeutics CEO Martine Rothblatt Disposes of USD 5.18 Million in Common Shares

Reuters
·
Jul 09

What United Therapeutics (UTHR)'s Centralized LungFX EVLP FDA Approval Means For Shareholders

Simply Wall St.
·
Jul 08

United Therapeutics is Maintained at Outperform by RBC Capital

Dow Jones
·
Jul 08

United Therapeutics CEO Martine Rothblatt Sells 9,500 Common Shares for $5.21 Million

Reuters
·
Jul 07

RBC Capital Raises United Therapeutics Price Target to $704 From $701, Maintains Outperform Rating

MT Newswires Live
·
Jul 07

United Therapeutics CEO Martine Rothblatt Disposes of 8,500 Common Shares Worth $4.63 Million

Reuters
·
Jul 03

United Therapeutics Acquires Thymmune Therapeutics for USD 140 Million Upfront

Reuters
·
Jul 02

United Therapeutics Corp - Deal Valued at $140 Mln Cash Plus up to $160 Mln in Earn-outs by 2031

THOMSON REUTERS
·
Jul 02

14 Value Stocks of Companies Primed for Rapid Growth Through 2028

Dow Jones
·
Jul 02

United Therapeutics CEO Martine Rothblatt Reports Disposal of 9,500 Common Shares Valued at $5.16 Million

Reuters
·
Jul 01

United Therapeutics IPF Opportunity Outweighs Base Business Risks, UBS Says

MT Newswires Live
·
Jul 01

United Therapeutics Shareholders Endorse 2026 Governance and Pay

TIPRANKS
·
Jun 30

United Therapeutics Chairperson, CEO Martine Rothblatt Disposes of 9,500 Common Shares for $5.12 Million

Reuters
·
Jun 30

United Therapeutics Shareholders Approve 2026 Stock Incentive Plan at Annual Meeting

Reuters
·
Jun 30

United Therapeutics Wins FDA Approval for Lungfx Lung Perfusion Device

Reuters
·
Jun 29

United Therapeutics Corp - Lung Bioengineering Expects to Add Lungfx to Services in 2027

THOMSON REUTERS
·
Jun 29

United Therapeutics Corporation Announces FDA Approval of the Lungfx™ Device for Centralized Ex Vivo Lung Perfusion

THOMSON REUTERS
·
Jun 29